Octaplas
STN: 125416
Proper Name: Pooled Plasma (Human), Solvent/Detergent Treated
Tradename: Octaplas
Manufacturer: Octapharma Pharmazeutika Produktionsges.m.b.H.
Indication:
Octaplas is a solvent/detergent (S/D) treated, pooled human plasma indicated for
- Replacement of multiple coagulation factors in patients with acquired deficiencies
- Due to liver disease
- Undergoing cardiac surgery or liver transplantation
- Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP)
Product Information
Supporting Documents
- April 18, 2024 Approval Letter - Octaplas
- Clinical Memorandum - Octaplas
- February 25, 2021 Approval Letter - Octaplas
- March 29, 2019 Approval Letter - Octaplas
- Clinical Review (BLA 125416/140) - Octaplas
- Approval History, Letters, Review, and Related Documents - Octaplas
- Supporting Documents older than three years - Octaplas